Derivados espiráncos sustituidos de cadena lineal

La presente invención se refiere a agentes farmacéuticos útiles para la terapia y/o profilaxis en un mamífero, a una composición farmacéutica que comprende tales compuestos y a su uso como inhibidores de la interacción proteína/proteína de la menina/MLL, útiles para tratar enfermedades tales como el...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LI, Kangying, THURING, Johannes Wilhelmus John F, DARVILLE, Nicolas Freddy J, DAI, Xuedong, XU, Yanping, FANG, Lichao, FU, Liqiang, NG, Alicia Tee Fuay, URBANIETZ, Gregor Thomas, DENG, Xiangjun, MATON, William, Marc, ZHAO, Qiwu, PANDE, Vineet, LIU, Yingtao, CAI, Wei, QUEROLLE, Olivier Alexis Georges, CLEATOR, Edward, LIU, Lianzhu, LI, Ming
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LI, Kangying
THURING, Johannes Wilhelmus John F
DARVILLE, Nicolas Freddy J
DAI, Xuedong
XU, Yanping
FANG, Lichao
FU, Liqiang
NG, Alicia Tee Fuay
URBANIETZ, Gregor Thomas
DENG, Xiangjun
MATON, William, Marc
ZHAO, Qiwu
PANDE, Vineet
LIU, Yingtao
CAI, Wei
QUEROLLE, Olivier Alexis Georges
CLEATOR, Edward
LIU, Lianzhu
LI, Ming
description La presente invención se refiere a agentes farmacéuticos útiles para la terapia y/o profilaxis en un mamífero, a una composición farmacéutica que comprende tales compuestos y a su uso como inhibidores de la interacción proteína/proteína de la menina/MLL, útiles para tratar enfermedades tales como el cáncer, que incluye, sin carácter limitante, leucemia, síndrome mielodisplásico (SMD) y neoplasias mieloproliferativas (NMP); y diabetes. The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CL2022001583A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CL2022001583A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CL2022001583A13</originalsourceid><addsrcrecordid>eNrjZDBySS3KLEtMyS9WSC0uyCw6vDAvGcguLi0uySwpzQSJp6QqJCempOYlKuRk5qUm5vAwsKYl5hSn8kJpbgZlN9cQZw_d1IL8eKAhicmpeakl8c4-RgZGRgYGhqYWxo6GxsSpAgDuri2u</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Derivados espiráncos sustituidos de cadena lineal</title><source>esp@cenet</source><creator>LI, Kangying ; THURING, Johannes Wilhelmus John F ; DARVILLE, Nicolas Freddy J ; DAI, Xuedong ; XU, Yanping ; FANG, Lichao ; FU, Liqiang ; NG, Alicia Tee Fuay ; URBANIETZ, Gregor Thomas ; DENG, Xiangjun ; MATON, William, Marc ; ZHAO, Qiwu ; PANDE, Vineet ; LIU, Yingtao ; CAI, Wei ; QUEROLLE, Olivier Alexis Georges ; CLEATOR, Edward ; LIU, Lianzhu ; LI, Ming</creator><creatorcontrib>LI, Kangying ; THURING, Johannes Wilhelmus John F ; DARVILLE, Nicolas Freddy J ; DAI, Xuedong ; XU, Yanping ; FANG, Lichao ; FU, Liqiang ; NG, Alicia Tee Fuay ; URBANIETZ, Gregor Thomas ; DENG, Xiangjun ; MATON, William, Marc ; ZHAO, Qiwu ; PANDE, Vineet ; LIU, Yingtao ; CAI, Wei ; QUEROLLE, Olivier Alexis Georges ; CLEATOR, Edward ; LIU, Lianzhu ; LI, Ming</creatorcontrib><description>La presente invención se refiere a agentes farmacéuticos útiles para la terapia y/o profilaxis en un mamífero, a una composición farmacéutica que comprende tales compuestos y a su uso como inhibidores de la interacción proteína/proteína de la menina/MLL, útiles para tratar enfermedades tales como el cáncer, que incluye, sin carácter limitante, leucemia, síndrome mielodisplásico (SMD) y neoplasias mieloproliferativas (NMP); y diabetes. The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230203&amp;DB=EPODOC&amp;CC=CL&amp;NR=2022001583A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230203&amp;DB=EPODOC&amp;CC=CL&amp;NR=2022001583A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LI, Kangying</creatorcontrib><creatorcontrib>THURING, Johannes Wilhelmus John F</creatorcontrib><creatorcontrib>DARVILLE, Nicolas Freddy J</creatorcontrib><creatorcontrib>DAI, Xuedong</creatorcontrib><creatorcontrib>XU, Yanping</creatorcontrib><creatorcontrib>FANG, Lichao</creatorcontrib><creatorcontrib>FU, Liqiang</creatorcontrib><creatorcontrib>NG, Alicia Tee Fuay</creatorcontrib><creatorcontrib>URBANIETZ, Gregor Thomas</creatorcontrib><creatorcontrib>DENG, Xiangjun</creatorcontrib><creatorcontrib>MATON, William, Marc</creatorcontrib><creatorcontrib>ZHAO, Qiwu</creatorcontrib><creatorcontrib>PANDE, Vineet</creatorcontrib><creatorcontrib>LIU, Yingtao</creatorcontrib><creatorcontrib>CAI, Wei</creatorcontrib><creatorcontrib>QUEROLLE, Olivier Alexis Georges</creatorcontrib><creatorcontrib>CLEATOR, Edward</creatorcontrib><creatorcontrib>LIU, Lianzhu</creatorcontrib><creatorcontrib>LI, Ming</creatorcontrib><title>Derivados espiráncos sustituidos de cadena lineal</title><description>La presente invención se refiere a agentes farmacéuticos útiles para la terapia y/o profilaxis en un mamífero, a una composición farmacéutica que comprende tales compuestos y a su uso como inhibidores de la interacción proteína/proteína de la menina/MLL, útiles para tratar enfermedades tales como el cáncer, que incluye, sin carácter limitante, leucemia, síndrome mielodisplásico (SMD) y neoplasias mieloproliferativas (NMP); y diabetes. The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBySS3KLEtMyS9WSC0uyCw6vDAvGcguLi0uySwpzQSJp6QqJCempOYlKuRk5qUm5vAwsKYl5hSn8kJpbgZlN9cQZw_d1IL8eKAhicmpeakl8c4-RgZGRgYGhqYWxo6GxsSpAgDuri2u</recordid><startdate>20230203</startdate><enddate>20230203</enddate><creator>LI, Kangying</creator><creator>THURING, Johannes Wilhelmus John F</creator><creator>DARVILLE, Nicolas Freddy J</creator><creator>DAI, Xuedong</creator><creator>XU, Yanping</creator><creator>FANG, Lichao</creator><creator>FU, Liqiang</creator><creator>NG, Alicia Tee Fuay</creator><creator>URBANIETZ, Gregor Thomas</creator><creator>DENG, Xiangjun</creator><creator>MATON, William, Marc</creator><creator>ZHAO, Qiwu</creator><creator>PANDE, Vineet</creator><creator>LIU, Yingtao</creator><creator>CAI, Wei</creator><creator>QUEROLLE, Olivier Alexis Georges</creator><creator>CLEATOR, Edward</creator><creator>LIU, Lianzhu</creator><creator>LI, Ming</creator><scope>EVB</scope></search><sort><creationdate>20230203</creationdate><title>Derivados espiráncos sustituidos de cadena lineal</title><author>LI, Kangying ; THURING, Johannes Wilhelmus John F ; DARVILLE, Nicolas Freddy J ; DAI, Xuedong ; XU, Yanping ; FANG, Lichao ; FU, Liqiang ; NG, Alicia Tee Fuay ; URBANIETZ, Gregor Thomas ; DENG, Xiangjun ; MATON, William, Marc ; ZHAO, Qiwu ; PANDE, Vineet ; LIU, Yingtao ; CAI, Wei ; QUEROLLE, Olivier Alexis Georges ; CLEATOR, Edward ; LIU, Lianzhu ; LI, Ming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CL2022001583A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LI, Kangying</creatorcontrib><creatorcontrib>THURING, Johannes Wilhelmus John F</creatorcontrib><creatorcontrib>DARVILLE, Nicolas Freddy J</creatorcontrib><creatorcontrib>DAI, Xuedong</creatorcontrib><creatorcontrib>XU, Yanping</creatorcontrib><creatorcontrib>FANG, Lichao</creatorcontrib><creatorcontrib>FU, Liqiang</creatorcontrib><creatorcontrib>NG, Alicia Tee Fuay</creatorcontrib><creatorcontrib>URBANIETZ, Gregor Thomas</creatorcontrib><creatorcontrib>DENG, Xiangjun</creatorcontrib><creatorcontrib>MATON, William, Marc</creatorcontrib><creatorcontrib>ZHAO, Qiwu</creatorcontrib><creatorcontrib>PANDE, Vineet</creatorcontrib><creatorcontrib>LIU, Yingtao</creatorcontrib><creatorcontrib>CAI, Wei</creatorcontrib><creatorcontrib>QUEROLLE, Olivier Alexis Georges</creatorcontrib><creatorcontrib>CLEATOR, Edward</creatorcontrib><creatorcontrib>LIU, Lianzhu</creatorcontrib><creatorcontrib>LI, Ming</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LI, Kangying</au><au>THURING, Johannes Wilhelmus John F</au><au>DARVILLE, Nicolas Freddy J</au><au>DAI, Xuedong</au><au>XU, Yanping</au><au>FANG, Lichao</au><au>FU, Liqiang</au><au>NG, Alicia Tee Fuay</au><au>URBANIETZ, Gregor Thomas</au><au>DENG, Xiangjun</au><au>MATON, William, Marc</au><au>ZHAO, Qiwu</au><au>PANDE, Vineet</au><au>LIU, Yingtao</au><au>CAI, Wei</au><au>QUEROLLE, Olivier Alexis Georges</au><au>CLEATOR, Edward</au><au>LIU, Lianzhu</au><au>LI, Ming</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Derivados espiráncos sustituidos de cadena lineal</title><date>2023-02-03</date><risdate>2023</risdate><abstract>La presente invención se refiere a agentes farmacéuticos útiles para la terapia y/o profilaxis en un mamífero, a una composición farmacéutica que comprende tales compuestos y a su uso como inhibidores de la interacción proteína/proteína de la menina/MLL, útiles para tratar enfermedades tales como el cáncer, que incluye, sin carácter limitante, leucemia, síndrome mielodisplásico (SMD) y neoplasias mieloproliferativas (NMP); y diabetes. The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_CL2022001583A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Derivados espiráncos sustituidos de cadena lineal
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T01%3A50%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LI,%20Kangying&rft.date=2023-02-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECL2022001583A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true